Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Trophos SA

Home Clinical Trial Sponsors and OrganizationsTrophos SA

Trophos SA

ACTIVE

Francewww.trophos.comSubsidiary11–50 employeesEstablished: 1998-01-01

Part of Roche Holding AG

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

16

15 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1998

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

10

62.5%

Phase 2

1

6.3%

Trial Status Distribution

Active, not recruiting

15

93.8%

Completed

1

6.3%

Clinical Trials

Trials sponsored by this organization (16)

Safety and efficacy study of TRO40303 for reduction of reperfusion injury in patients undergoing Percutaneous Coronary Intervention for acute myocardial infarctio

Active, not recruiting

Safety and efficacy study of TRO40303 for reduction of reperfusion injury in patients undergoing Percutaneous Coronary Intervention for acute myocardial infarctio

Active, not recruiting

Jul 2011180 participants

Phase II, multicenter, randomized, adaptive, double-blind,placebo controlled Study to assess Safety and Efficacy of olesoxime(TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients

Jun 2011165 participants

An Open Label Safety Extension Study of olesoxime (TRO19622) in Amyotrophic Lateral SclerosisUn extensión del estudio en abierto de la seguridad del TRO19622 en Esclerosis Lateral Amiotrófica (ELA)de los pacientes tratados con riluzol.

Active, not recruiting

An Open-Label Safety Extension Study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) patients treated with riluzole.

Active, not recruiting

An Open-Label Safety Extension Study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) patients treated with riluzole.

Active, not recruiting

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 yrs SMA patients

Active, not recruiting

Oct 2010165 participants

Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients.

Active, not recruiting

Jul 2010150 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials16
Approvals
News

Back to Organizations